
Press Release March 22, 2023
Drugs for rare diseases announcement is a step forward for patients
Ottawa, March 22, 2023 – Innovative Medicines Canada (IMC) is encouraged by the federal government’s announcement regarding its intentions for […]
Our news library that includes all press releases and industry related news.
Press Release March 22, 2023
Ottawa, March 22, 2023 – Innovative Medicines Canada (IMC) is encouraged by the federal government’s announcement regarding its intentions for […]
In the news February 28, 2023
This article originally appeared in Maclean’s print and healthinsights.ca on February 16, 2023 Canada desperately needs a rare disease strategy that’ll enable […]
Press Release February 14, 2023
Ottawa, February 14, 2023 – With Rare Disease Day fast approaching, the federal government has an opportunity to make a […]
Press Release February 01, 2023
Ottawa, ON – Innovative Medicines Canada (IMC) welcomes the new leadership of the Patented Medicine Prices Review Board (PMPRB) with […]
In the news January 25, 2023
This article originally appeared in Research Money on January 25, 2023. A dwindling workforce, inefficient regulations, and lack of much-needed […]
In the news January 13, 2023
We need to work together to evolve the private market so that it continues to have the value of providing […]
In the news December 20, 2022
Pamela Fralick, President, Innovative Medicines Canada This article originally appeared in National Newswatch on December 20, 2022. In 2019, the […]
Press Release December 19, 2022
Ottawa, ON – Innovative Medicines Canada (IMC) welcomes the Patented Medicine Prices Review Board (PMPRB) announcement to delay the implementation […]
In the news December 15, 2022
Pamela Fralick, President, Innovative Medicines Canada *This article originally appeared in the Toronto Star on December 15, 2022. In 2016, […]
Press Release December 15, 2022
Ottawa, ON – Following the resignation of the Patented Medicine Prices Review Board’s (PMPRB) Acting Chairperson last week, Innovative Medicines […]
Press Release December 05, 2022
Ottawa, ON – Innovative Medicines Canada (IMC) has submitted formal feedback to the Patented Medicine Prices Review Board’s (PMPRB) revised […]
Press Release November 22, 2022
Ottawa, ON – Innovative Medicines Canada (IMC) is once again disappointed by the inaccurate and misleading information on the value […]
Informative content to keep you up to date on the most pressing issues facing our industry.